AbTherx Appoints Jessica Stark, PhD, as Scientific Advisor
Accesswire
*Glycoimmunology expert and co-inventor of AbLec technology joins AbTherx to expand expertise around challenging drug..
Koch Institute for Integrative Cancer Research
News and Video Search Results
News coverage
-
Whittier Street Health Center to Honor Vertex Pharmaceuticals Executive Chairman Jeffrey Leiden at Its 2024 Annual Gala
Accesswire
-
Riding the tide, realize the future: The BD paths for Chinese Biotech
PR Newswire Asia
-
Elicio Therapeutics Announces Positive Interim Data from the Phase 1 Study of an Investigational Therapeutic Cancer Immunotherapy, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at the ASCO Annual Meeting
GlobeNewswire
-
Elicio Therapeutics Reports Inducement Grant to New Chief Financial Officer
GlobeNewswire
- More about:
Robert S. Langer
0 shares
1 views
You might like
Koch Institute for Integrative Cancer Research media coverage
EMIT IMAGING Collaborates with MIT Koch Institute for Integrative Cancer Research to Enhance Cryo-Fluorescence Tomography Technology
Business Wire
BALTIMORE--(BUSINESS WIRE)--EMIT IMAGING Collaborates with MIT Koch Institute for Integrative Cancer Research to Enhance..
-
IMUNON Reports 2022 Financial Results and Provides Business Update
GlobeNewswire
-
IMUNON and Break Through Cancer Commence Enrollment in a Phase 1/2 Clinical Study of IMNN-001 in Combination with Avastin in Advanced Ovarian Cancer
GlobeNewswire
-
Elicio Therapeutics and Angion Enter into Definitive Merger Agreement
GlobeNewswire
-
AIChE Honors Organizations and Leaders for Engineering the Extraordinary
GlobeNewswire
Advertisement
More coverage
Scientists Are Using Microparticles To Develop a Self-Boosting Vaccine
Wibbitz Top Stories
Scientists Are Using Microparticles, to Develop a, Self-Boosting Vaccine.
'Newsweek' reports that scientists are..
-
Elicio Therapeutics Presents Preclinical Data on AMP-CpG Adjuvant in Combination with EBV Vaccine at the 2022 Keystone Symposia: Viral Immunity: Basic Mechanisms and Therapeutic Applications
GlobeNewswire
-
Elicio Therapeutics Presents Design of Ongoing AMPLIFY-201 Study in Mutant KRAS-Driven Cancers at ASCO Annual Meeting 2022
GlobeNewswire
-
Elicio Therapeutics Presents Preclinical Data on the AMP-Peptide Vaccine in Combination with TCR-T Cell Therapy for Solid Tumors at the 2022 Keystone Symposia: Emerging Cellular Therapies
GlobeNewswire
-
Elicio Therapeutics Presents Updated Preclinical Data at Vaccines Summit Boston 2022 on ELI-005, a Lymph Node-Targeted Amphiphile Vaccine, Demonstrating It Induces Potent Cross-Reactive Cellular and Humoral Immunity to SARS-CoV-2
GlobeNewswire